Eyenovia - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsEyenovia

Eyenovia(EYEN)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Mydcombi	Phenylephrine, Tropicamide	2023-05-05	2031-2036	Septic shock , Hypotension , Pruritus ani , Pain , Postoperative pain , Open-angle glaucoma , Fissure in ano , Intraocular lens implantation , Hemorrhoids , Vasomotor rhinitis , Supraventricular tachycardia , Juvenile arthritis , Menorrhagia , Ankylosing spondylitis , Rheumatoid arthritis , Fever , Inflammation , Osteoarthritis , Bursitis , Dysmenorrhea , Gout , Premenstrual syndrome , Allergic rhinitis perennial , Urticaria , Photophobia , Allergic conjunctivitis , Low cardiac output , Bradycardia , Heart arrest , Ventricular fibrillation , Hemorrhagic shock , Torsades de pointes , Adams-stokes syndrome , Pruritus , Allergic rhinitis seasonal , Postoperative complications , Vomiting , Nausea , Anaphylaxis , Cough , Motion sickness , Keratitis , Iritis , Iridocyclitis
Clobetasol	Clobetasol	2024-03-04	2025-2035	Inflammation , Dermatitis , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

,

respiratory distress syndrome

,

newborn respiratory distress syndrome

hypersensitivity

hypersensitivity

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use